Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Bebin

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
Archives of Neurology|June 18, 2003
Temporal lobectomy in congenital porencephaly associated with hippocampal sclerosisJorge G Burneo, Edward Faught, Robert C Knowlton, et al.
Epilepsia|December 27, 2021
Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trialElizabeth A Thiele, E Martina Bebin, Francis Filloux, et al.
Epilepsy & Behavior : E&B|July 17, 2021
Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsyLeslie Grayson, Steve Ampah, Kathleen Hernando, et al.
Epilepsia|April 20, 2007
Pharmacokinetics of levetiracetam in infants and young children with epilepsyTracy A Glauser, Wendy G Mitchell, Arie Weinstock, et al.
Epilepsy & Behavior : E&B|June 21, 2019
Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsyRoy C Martin, Tyler E Gaston, Matthew Thompson, et al.
Epilepsy & Behavior : E&B|May 4, 2019
Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiolJerzy P Szaflarski, Kathleen Hernando, E Martina Bebin, et al.
Epilepsy & Behavior : E&B|August 6, 2019
Drug-drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access ProgramTyler E Gaston, E Martina Bebin, Gary R Cutter, et al.
Epilepsy & Behavior : E&B|September 2, 2020
Effects of highly purified cannabidiol (CBD) on fMRI of working memory in treatment-resistant epilepsyTyler E Gaston, Jane B Allendorfer, Sangeeta Nair, et al.
Epilepsy & Behavior : E&B|August 8, 2020
Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsyMatthew D Thompson, Roy C Martin, Leslie P Grayson, et al.
Epilepsy & Behavior : E&B|August 4, 2020
Cannabidiol normalizes resting-state functional connectivity in treatment-resistant epilepsyRodolphe Nenert, Jane B Allendorfer, E Martina Bebin, et al.
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
Archives of Neurology|June 18, 2003
Temporal lobectomy in congenital porencephaly associated with hippocampal sclerosisJorge G Burneo, Edward Faught, Robert C Knowlton, et al.
Epilepsia|December 27, 2021
Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trialElizabeth A Thiele, E Martina Bebin, Francis Filloux, et al.
Epilepsy & Behavior : E&B|July 17, 2021
Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsyLeslie Grayson, Steve Ampah, Kathleen Hernando, et al.
Epilepsia|April 20, 2007
Pharmacokinetics of levetiracetam in infants and young children with epilepsyTracy A Glauser, Wendy G Mitchell, Arie Weinstock, et al.
Epilepsy & Behavior : E&B|June 21, 2019
Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsyRoy C Martin, Tyler E Gaston, Matthew Thompson, et al.
Epilepsy & Behavior : E&B|May 4, 2019
Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiolJerzy P Szaflarski, Kathleen Hernando, E Martina Bebin, et al.
Epilepsy & Behavior : E&B|August 6, 2019
Drug-drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access ProgramTyler E Gaston, E Martina Bebin, Gary R Cutter, et al.
Epilepsy & Behavior : E&B|September 2, 2020
Effects of highly purified cannabidiol (CBD) on fMRI of working memory in treatment-resistant epilepsyTyler E Gaston, Jane B Allendorfer, Sangeeta Nair, et al.
Epilepsy & Behavior : E&B|August 8, 2020
Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsyMatthew D Thompson, Roy C Martin, Leslie P Grayson, et al.
Epilepsy & Behavior : E&B|August 4, 2020
Cannabidiol normalizes resting-state functional connectivity in treatment-resistant epilepsyRodolphe Nenert, Jane B Allendorfer, E Martina Bebin, et al.
Pageof 12